Lachelle Dawn
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Lachelle Dawn
Jun 29, 2024, 16:24 |
Insight
Anand Patel: Highlighting challenges in MPNs at SOHO 2024
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago,…
Jun 26, 2024, 05:00 |
Blog
Lachelle Dawn: Fellows can join the Dana Farber’s division of Leukemia
Lachelle Dawn, Hematologist and Scientist at Dana-Farber Cancer Institute, shared on X: “I work with…
Feb 17, 2024, 17:38 |
Career
Laurie Glimcher: Congratulations to Lachelle Dawn on receiving American Society for Clinical Investigation 2024 Young Physician-Scientist Award
Laurie Glimcher, President and CEO of Dana-Farber Cancer Institute, shared on X/Twitter: ''Congratulations to our…
Nov 7, 2023, 18:03 |
Insight
Lachelle Dawn: Excited to share our review article in Blood Journal on the Causes and Consequences of Clonal Hematopoiesis
Lachelle Dawn, Hematologist and Scientist at Dana-Farber Cancer Institute, shared on Twitter: "Excited to share…
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube